Archer S
Veterans Administration Medical Center Minneapolis, Minnesota 55417.
FASEB J. 1993 Feb 1;7(2):349-60. doi: 10.1096/fasebj.7.2.8440411.
Nitric oxide (NO) is a small, gaseous, paramagnetic radical with a high affinity for interaction with ferrous hemoproteins such as soluble guanylate cyclase and hemoglobin. Interest in NO measurement increased exponentially with the discovery that NO or a related compound is the endothelium-derived relaxing factor (EDRF). In addition to being a potent endogenous vasodilator, NO has a role in inflammation, thrombosis, immunity, and neurotransmission. Measurement of NO is important as many of its effects (e.g., vasodilatation, inhibition of platelet aggregation) are similar to those of other substances produced by the endothelium, such as prostacyclin. NO is formed in small amounts in vivo and is rapidly destroyed by interaction with oxygen, making measurement difficult. A computerized search of the past five year's literature found NO measurements reported in fewer than 50 of 955 articles dealing with EDRF. Inhibitors of NO synthesis such as the arginine analogs or agents that inactivate NO, such as reduced hemoglobin, are commonly used as specific probes for NO, in vivo and in vitro; however, none of the NO inhibitors is completely specific. The most widely used assays use one of three strategies to detect NO: 1) NO is "trapped" by nitroso compounds, or reduced hemoglobin, forming a stable adduct that is detected by electron paramagnetic resonance (EPR) (detection threshold approximately 1 nmol); 2) NO oxidizes reduced hemoglobin to methemoglobin, which is detected by spectrophotometry (detection threshold approximately 1 nmol); 3) NO interacts with ozone producing light, "chemiluminescence" (detection threshold approximately 20 pmol). These assays can be performed to exclusively detect NO, or by adding acid and reducing agents to the sample, can measure NO and related oxides of nitrogen such as nitrite. Several new amperometric microelectrode assays offer the potential to measure smaller amounts of NO (10(-20) M), permitting NO measurement in intact issues and from single cells. This review describes the pharmacology and toxicology of NO and reviews the major techniques for measuring NO in biological models.
一氧化氮(NO)是一种小分子气态顺磁性自由基,它与亚铁血红素蛋白(如可溶性鸟苷酸环化酶和血红蛋白)具有很高的亲和力,易于相互作用。随着一氧化氮或相关化合物是内皮衍生舒张因子(EDRF)这一发现,对一氧化氮测量的关注呈指数级增长。一氧化氮除了是一种强大的内源性血管舒张剂外,还在炎症、血栓形成、免疫和神经传递中发挥作用。一氧化氮的测量很重要,因为它的许多作用(如血管舒张、抑制血小板聚集)与内皮产生的其他物质(如前列环素)相似。一氧化氮在体内少量形成,并通过与氧气相互作用迅速被破坏,这使得测量变得困难。对过去五年文献进行的计算机检索发现,在955篇关于内皮衍生舒张因子的文章中,报道一氧化氮测量的文章不到50篇。一氧化氮合成抑制剂(如精氨酸类似物)或使一氧化氮失活的试剂(如还原血红蛋白)通常在体内和体外用作一氧化氮的特异性探针;然而,没有一种一氧化氮抑制剂是完全特异性的。最广泛使用的检测方法使用三种策略之一来检测一氧化氮:1)一氧化氮被亚硝基化合物或还原血红蛋白“捕获”,形成稳定的加合物,通过电子顺磁共振(EPR)检测(检测阈值约为1 nmol);2)一氧化氮将还原血红蛋白氧化为高铁血红蛋白,通过分光光度法检测(检测阈值约为1 nmol);3)一氧化氮与臭氧相互作用产生光,即“化学发光”(检测阈值约为20 pmol)。这些检测方法可以专门用于检测一氧化氮,或者通过向样品中添加酸和还原剂,可以测量一氧化氮和相关的氮氧化物(如亚硝酸盐)。几种新的安培微电极检测方法有可能测量更少的一氧化氮(10⁻²⁰ M),从而能够在完整组织和单细胞中测量一氧化氮。本综述描述了一氧化氮的药理学和毒理学,并综述了在生物模型中测量一氧化氮的主要技术。